Viewing Study NCT03836105


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-02-20 @ 6:35 PM
Study NCT ID: NCT03836105
Status: COMPLETED
Last Update Posted: 2025-10-15
First Post: 2019-02-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CemiplimAb Survivorship Epidemiology
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module